UTMB develops AI pipeline for alphavirus vaccines amid rising mosquito-borne threats
Scientists at The University of Texas Medical Branch have created an AI-driven pipeline to expedite vaccine development against alphaviruses. The initiative aims to address the growing threat of mosquito-borne viruses. This development comes as global health concerns over such viruses increase.
AI-Driven Vaccine Development
The University of Texas Medical Branch, led by Nikos Vasilakis and Peter McCaffrey, has introduced a computational pipeline leveraging artificial intelligence to speed up vaccine creation. This pipeline targets alphaviruses, a group of mosquito-borne viruses. The project involves collaboration with researchers from Brazil and Panama, highlighting international cooperation in combating viral threats.
Research Team and Collaborations
Nikos Vasilakis, a professor and vice chair for research, and Peter McCaffrey, director of the UTMB AI center, spearheaded the project. The initiative is part of the Department of Pathology's efforts to enhance vaccine research. Collaborations with Brazilian and Panamanian scientists underscore the global nature of the research, aiming to mitigate the impact of alphaviruses worldwide.
What's Next
The research team plans to test the pipeline's effectiveness in upcoming trials. The success of these trials remains uncertain as researchers await results.
1 source
UTMB develops AI pipeline for alphavirus vaccines amid rising mosquito-borne threats
